Safety and effectiveness of endovascular treatment after 6 hours of symptom onset in patients with anterior circulation ischemic stroke: a matched case control study.

[1]  A. Qureshi,et al.  Increased Rate of Aspiration Pneumonia and Poor Discharge Outcome Among Acute Ischemic Stroke Patients Following Intubation for Endovascular Treatment , 2012, Neurocritical Care.

[2]  D. Anderson,et al.  Agreement in Endovascular Thrombolysis Patient Selection Based on Interpretation of Presenting CT and CT-P Changes in Ischemic Stroke Patients , 2012, Neurocritical Care.

[3]  A. Qureshi,et al.  MRI‐Assisted Thrombolysis for Delayed Arrival Among Patients With Ischemic Stroke , 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[4]  A. Rai,et al.  Imaging-Based Endovascular Therapy for Acute Ischemic Stroke due to Proximal Intracranial Anterior Circulation Occlusion Treated Beyond 8 Hours From Time Last Seen Well: Retrospective Multicenter Analysis of 237 Consecutive Patients , 2011, Stroke.

[5]  J. Grotta,et al.  Early stroke treatment associated with better outcome: the ninds rt-pa stroke study , 2000, Neurology.

[6]  G. Gravlee.  Conscious Sedation Versus General Anesthesia During Endovascular Therapy for Acute Anterior Circulation Stroke: Preliminary Results From a Retrospective, Multicenter Study , 2011 .

[7]  C. Beaulieu,et al.  Low Cerebral Blood Volume Is Predictive of Diffusion Restriction Only in Hyperacute Stroke , 2010, Stroke.

[8]  A. Qureshi,et al.  A Comparison of Computed Tomography Perfusion-Guided and Time-Guided Endovascular Treatments for Patients With Acute Ischemic Stroke , 2010, Stroke.

[9]  A. Qureshi,et al.  Occurrence and Predictors of Futile Recanalization following Endovascular Treatment among Patients with Acute Ischemic Stroke: A Multicenter Study , 2010, American Journal of Neuroradiology.

[10]  Jeffrey L Saver,et al.  Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. , 2009, Stroke.

[11]  J. Pile-Spellman,et al.  Late Endovascular Revascularization in Acute Ischemic Stroke Based on Clinical-Diffusion Mismatch , 2009, American Journal of Neuroradiology.

[12]  A. Qureshi,et al.  Subacute Recanalization and Reocclusion in Patients with Acute Ischemic Stroke Following Endovascular Treatment , 2009, Neurocritical Care.

[13]  S. Warach,et al.  Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study , 2009, The Lancet Neurology.

[14]  J. Broderick,et al.  Microcatheter Contrast Injections During Intra-Arterial Thrombolysis May Increase Intracranial Hemorrhage Risk , 2008, Stroke.

[15]  K. Lakshminarayan,et al.  Endovascular Interventions following Intravenous Thrombolysis May Improve Survival and Recovery in Patients with Acute Ischemic Stroke: A Case-Control Study , 2008, American Journal of Neuroradiology.

[16]  Q. Shah,et al.  Clinical and radiological outcomes of acute ischemic stroke patients without angiographic occlusion on digital subtraction angiogram. A pooled analysis of case series , 2008, Neuroradiology.

[17]  N. Janjua,et al.  Impact of Arterial Reocclusion and Distal Fragmentation during Thrombolysis among Patients with Acute Ischemic Stroke , 2008, American Journal of Neuroradiology.

[18]  A. Divani,et al.  Changes in Cost and Outcome Among US Patients With Stroke Hospitalized in 1990 to 1991 and Those Hospitalized in 2000 to 2001 , 2007, Stroke.

[19]  A. Divani,et al.  Mechanical Disruption of Thrombus Following Intravenous Tissue Plasminogen Activator for Ischemic Stroke , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[20]  A. Divani,et al.  Intra-arterial Reteplase and Intravenous Abciximab in Patients with Acute Ischemic Stroke: An Open-label, Dose-ranging, Phase I Study , 2006, Neurosurgery.

[21]  Steven Warach,et al.  Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of Safety and Efficacy 3 to 9 Hours After Stroke Onset , 2006, Stroke.

[22]  G. Hankey,et al.  Results of a Multicentre, Randomised Controlled Trial of Intra-Arterial Urokinase in the Treatment of Acute Posterior Circulation Ischaemic Stroke , 2005, Cerebrovascular Diseases.

[23]  L. Hershey,et al.  Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke , 2005, Neurology.

[24]  S. Warach,et al.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase , 2005, Stroke.

[25]  Scott Hamilton,et al.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials , 2004, The Lancet.

[26]  A. Qureshi,et al.  Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. , 2004, AJNR. American journal of neuroradiology.

[27]  J T Kuikka,et al.  Combined diffusion and perfusion MRI with correlation to single-photon emission CT in acute ischemic stroke. Ischemic penumbra predicts infarct growth. , 1999, Stroke.

[28]  Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. , 1998, JAMA.

[29]  M. Ginsberg,et al.  The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke , 1994, Annals of neurology.